lobbying_activities: 1920984

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1920984	d7679e46-e9ae-4755-bd6f-bb34aeb1b346	Q4	FORBES-TATE	400976792	PHRMA	2016	fourth_quarter	PHA	Issues related to Medicare Part D; Issues related to the drug industry; Issues related to comparative effectiveness; Issues related to follow-on biologics; Issues related to the Independent Payment Advisory Board; Issues related to patent reform; Issues related to ASP+6 and Part B rule; Issues related to PCORI; Issues related to pharmaceutical drug safety track and trace program legislation; Issues related to low income subsidies; Issues related to the Vice President's National Cancer Moonshot Initiative.	HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2017-01-19T10:16:19-05:00